Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility

Quick Summary:

Shares of Marksans Pharma soared up to 1.98 per cent at Rs 220.

A 'VAI' status means that objectionable conditions were found, but the regulator is not prepared to take or recommend any administrative or regulatory action.

The US FDA had inspected the manufacturing facility located at Verna Industrial estate, Verna, Goa, India from April 09, 2024 to April 17, 2024.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaUnited States

Topics: Marksans pharma share price Stock market Marksans pharma shares Marksans pharma Marksans pharma share price Buzzing stocks Marksans pharma share price today Sensex

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-08-20 @ 14:33:28 (7 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 450 words

Reading Time: 3 minutes read

Sentences: 20 lines

Sentence Length: 23 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 22173443

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 276 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions